MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

08 Aug 2026 Evaluate
The Revenue for the quarter ended  June 2026 of Rs. 437.90 millions grew by 22.07 % from Rs. 358.73 millions.Modest increase of 22.13% in the Net Profit was reported from. 90.62 millions to Rs. 110.67  millions.Operating profit for the quarter ended June 2026 rose to 209.26 millions as compared to 141.96 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 437.90 358.73 22.07 437.90 358.73 22.07 1658.23 1508.00 9.96
Other Income 1.32 2.74 -51.82 1.32 2.74 -51.82 24.28 24.32 -0.16
PBIDT 209.26 141.96 47.41 209.26 141.96 47.41 779.58 712.76 9.37
Interest 17.87 0.42 4154.76 17.87 0.42 4154.76 29.49 3.64 710.16
PBDT 191.39 141.54 35.22 191.39 141.54 35.22 750.09 709.12 5.78
Depreciation 39.73 20.34 95.33 39.73 20.34 95.33 129.19 53.75 140.35
PBT 151.66 121.20 25.13 151.66 121.20 25.13 620.90 655.37 -5.26
TAX 40.99 30.58 34.04 40.99 30.58 34.04 154.08 167.66 -8.10
Deferred Tax 13.82 5.92 133.45 13.82 5.92 133.45 46.22 2.80 1550.71
PAT 110.67 90.62 22.13 110.67 90.62 22.13 466.82 487.71 -4.28
Equity 108.97 108.97 0.00 108.97 108.97 0.00 108.97 108.97 0.00
PBIDTM(%) 47.79 39.57 20.76 47.79 39.57 20.76 47.01 47.27 -0.53

Guj. Themis Biosyn Share Price

356.50 -4.45 (-1.23%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: